Katarzyna Skrodzka
age 47Currently 7 roles in 5 KRS entities. In the KRS since 2018.
Roles
| Entity | Role | Since | Address |
|---|---|---|---|
Innova Capital sp. z o.o. |
since Aug 14, 2019 | Aug 14, 2019 | ul. Białołęcka 368C, 03-253 Warszawa |
Regal Development sp. z o.o. |
since Nov 4, 2021 | Nov 4, 2021 | ul. Białołęcka 368 C, 03-253 Warszawa |
since May 20, 2021 | May 20, 2021 | ul. Białołęcka 368C, 03-253 Warszawa | |
Regaldevelopment Wilanów sp. z o.o. |
since Jul 29, 2022 | Jul 29, 2022 | ul. Białołęcka 368 C, 03-253 Warszawa |
Innovapharm Polska sp. z o.o. |
since Jun 21, 2023 | Jun 21, 2023 | ul. Annopol 3, 03-236 Warszawa |
Connections graph
Change history
| Date | Event | Details | Entity |
|---|---|---|---|
| Appointed | Partner (50% of shares worth PLN 2,500) Innovapharm Polska sp. z o.o. | Innovapharm Polska sp. z o.o. | |
| Company founded | President of the Management Board Regaldevelopment Wilanów sp. z o.o. | Regaldevelopment Wilanów sp. z o.o. | |
| Left | Partner (50% of shares worth PLN 2,500) Innovapharm Polska sp. z o.o. | Innovapharm Polska sp. z o.o. | |
| Company founded | President of the Management Board Regal Development sp. z o.o. | Regal Development sp. z o.o. | |
| Company founded | Sole shareholder (100% of shares worth PLN 100,000), President of the Management Board | ||
| Company founded | President of the Management Board, Partner (50% of shares worth PLN 2,500) Innova Capital sp. z o.o. | Innova Capital sp. z o.o. | |
| Company founded | Partner (50% of shares worth PLN 2,500) Innovapharm Polska sp. z o.o. | Innovapharm Polska sp. z o.o. |
Business scale
Total for the entities where the person sat on the management board or held shares, for the years in office.
Risk signals
| Signal | Details |
|---|---|
Politically exposed person (PEP) | None |
Person on a sanctions list | None |
Bankruptcy or restructuring | None |
Liquidation | None |
Sanctions list | None |
Inactive entity | None |
Connected people
| Person | Shared entity | Period | |
|---|---|---|---|
Artur Skrodzkiage 48 | Innovapharm Polska sp. z o.o. | since Jun 21, 2018 | |
Karol Szulimage 42 | Innova Capital sp. z o.o. | since Aug 14, 2019 |